Methacrylic Acid

Methacrylic Acid

SCHEMBL3136829

C=C(C)C(=O)O.C=C(C)C(=O)O.[Si]

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.50
FFAR3 O14843 1/20 0.46
LCK P06239 1/20 0.46
FYN P06241 1/20 0.46
ALDH1A1 P00352 3/20 0.42
LMNA P02545 3/20 0.39
HSD17B10 Q99714 1/20 0.37
TSHR P16473 2/20 0.36
THPO P40225 1/20 0.36
CA1 P00915 3/20 0.33
TGFBR1 P36897 1/20 0.33
ALOX15 P16050 1/20 0.33
BLM P54132 1/20 0.33
PMP22 Q01453 1/20 0.33
KDM4E B2RXH2 1/20 0.32
TET2 Q6N021 1/20 0.32
LDHA P00338 1/20 0.31
LDHB P07195 1/20 0.31
CA2 P00918 1/20 0.31
CA9 Q16790 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methacrylic Acid SCHEMBL9717798 1.00 TDP1 (0.50) TDP1FFAR3LCKFYNALDH1A1
Methacrylic Acid SCHEMBL1265881 1.00
Methacrylic Acid SCHEMBL157355 1.00 TDP1 (0.50) TDP1FFAR3LCKFYNALDH1A1
Methacrylic Acid SCHEMBL28223053 1.00 TDP1 (0.50) TDP1FFAR3LCKFYNALDH1A1
Methacrylic Acid SCHEMBL456723 1.00 TDP1 (0.50) TDP1FFAR3LCKFYNALDH1A1
Methacrylic Acid SCHEMBL31424890 1.00
Methacrylic Acid SCHEMBL31424854 1.00 TDP1 (0.50) TDP1FFAR3LCKFYNALDH1A1
Methacrylic Acid SCHEMBL50618 1.00
Methacrylic Acid SCHEMBL21047224 1.00 TDP1 (0.50) TDP1FFAR3LCKFYNALDH1A1
Methacrylic Acid SCHEMBL30697369 0.96

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260132303-A1 PHOTOCURABLE INK COMPOSITIONS, AND PREPARATION METHOD AND APPLICATION THEREOF XI'AN SMART MATERIALS CO., LTD. (CN) 2026-05-14 US disclosed
EP-4582501-A1 PHOTOCURABLE INK COMPOSITION, AND PREPARATION METHOD THEREFOR AND USE THEREOF Xi'an Smart Materials Co., Ltd. (CN) 2025-07-09 EP disclosed
CN-113248652-B Photocurable composition for sealing organic light-emitting device 浙江华显光电科技有限公司 2022-09-16 CN disclosed
EP-1620502-B9 METHOD OF CURING A COMPOSITION BY METATHESIS REACTION USING REACTION CONTROL AGENT KERR CORP (US) 2010-07-14 EP disclosed
EP-1620502-B1 METHOD OF CURING A COMPOSITION BY METATHESIS REACTION USING REACTION CONTROL AGENT KERR CORP (US) 2009-08-12 EP disclosed
US-7060769-B2 Method of curing composition by metathesis reaction using reaction control agent KERR CORPORATION (US) 2006-06-13 US disclosed
EP-0652489-B1 Process for processing a photosensitive lithographic printing plate requiring no fountain solution FUJI PHOTO FILM CO LTD (JP) 1997-11-05 EP disclosed
US-5629136-A POLYSILOXANES FUJI PHOTO FILM CO., LTD. (JP) 1997-05-13 US disclosed
US-5580704-A CONTAINING BASIC DYE, ORGANIC SOLVENT HAVING LOW WATER SOLUBILITY, HYDROTROPE AGENT, ANIONIC SURFACTANT; HIGH DYE DENSITY, LOW FOAMABILITY, NONPRECIPITATING, NONSTAINING FUJI PHOTO FILM CO., LTD. (JP) 1996-12-03 US disclosed
EP-0652489-A1 Process for processing a photosensitive lithographic printing plate requiring no fountain solution FUJI PHOTO FILM CO., LTD. (JP) 1995-05-10 EP disclosed
US-5387105-A Using an acrylated polysiloxane DENTSPLY RESEARCH & DEVELOPMENT CORP. (US) 1995-02-07 US disclosed
US-5137448-A Curing elastomeric material with actinic radiaiton through tray while it is in place in oral cavity DENTSPLY RESEARCH & DEVELOPMENT CORP. (US) 1992-08-11 US disclosed
EP-0170219-A2 Dental image formation and organosiloxane DENTSPLY INTERNATIONAL, INC. (US) 1986-02-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260132303-A1 PHOTOCURABLE INK COMPOSITIONS, AND PREPARATION METHOD AND APPLICATION THEREOF C9, ILK, NOX1 TDP1 2941/4885FFAR3 2610/4885LCK 1656/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.